Why Eye Pressure Matters
Intraocular pressure (IOP) is the fluid pressure inside the eye. Elevated IOP is the primary modifiable risk factor for primary open-angle glaucoma, the leading cause of irreversible blindness worldwide. Normal IOP ranges from 10 to 21 mmHg. Sustained elevation above 21 mmHg increases the risk of optic nerve damage over time. For people already diagnosed with elevated IOP or glaucoma, understanding how dietary choices affect IOP is clinically relevant.Decaf vs Regular: A Direct Comparison
A 2025 study by Riaz et al., published in the Journal of the Pakistan Medical Association (DOI 10.47391/JPMA.20294), directly compared decaffeinated and caffeinated coffee in 73 human subjects. After caffeinated coffee, IOP rose significantly (p less than 0.001). After decaffeinated coffee, IOP showed no significant change (p greater than 0.05). The authors concluded that caffeine, not other coffee compounds, drives the IOP effect. This is the most directly applicable study for people asking whether they can drink coffee without raising eye pressure. The answer from this data is that switching to decaf eliminates the measurable acute IOP response.The Acute Caffeine Effect
A meta-analysis by Li et al. published in Graefe’s Archive for Clinical and Experimental Ophthalmology (DOI 10.1007/s00417-010-1455-1) pooled 6 randomized controlled trials with 144 participants. In people with glaucoma or ocular hypertension, IOP rose by a weighted mean difference of 2.39 mmHg at 1 hour post-caffeine (95% CI 1.74 to 3.05) and 2.00 mmHg at 1.5 hours. In healthy individuals without elevated IOP, no significant IOP change was observed. The mechanism is thought to involve caffeine’s effect on aqueous humor production and outflow resistance, though the precise pathway is not fully established.The Long-Term Paradox
A 2026 Mendelian randomization study by Dong et al., published in Experimental Gerontology (DOI 10.1016/j.exger.2026.113106), found that higher long-term plasma caffeine was associated with a reduced risk of primary open-angle glaucoma (OR 0.753, 95% CI 0.633 to 0.896). Approximately 54% of this protective effect was mediated through reduced IOP in the long-term data. This appears to contradict the acute experiment findings. The likely explanation is tolerance. Habitual caffeine users develop tolerance to the acute IOP-elevating effect over time, while the long-term vascular and neuroprotective effects of caffeine may confer some protection. This means the acute IOP studies are most relevant to occasional coffee drinkers or people already diagnosed with elevated IOP, while the Dong 2026 findings may reflect the physiology of habitual users. For someone already managed medically for elevated IOP or diagnosed glaucoma, their ophthalmologist will typically advise caution about acute IOP-elevating stimuli, regardless of the population-level long-term associations.Who This Research Is Most Relevant For
The acute IOP effect of caffeine is most clinically significant for three groups. First, people with diagnosed primary open-angle glaucoma who are managing IOP with medication or surgery and want to avoid dietary triggers of acute elevation. Second, people with ocular hypertension (IOP above 21 mmHg without optic nerve damage) who are under monitoring. Third, people who have had IOP-sensitive procedures such as LASIK or certain forms of cataract surgery, where temporary IOP fluctuations may be a concern. For all three groups, the Riaz 2025 data showing no significant IOP change from decaf is directly relevant.What Colipse Coffee offers for eye pressure management
How each product relates to eye pressure
Dark Roast Decaf eliminates the mechanism behind caffeine’s acute IOP elevation: adenosine receptor blockade in the trabecular meshwork that transiently reduces aqueous humor outflow. The 2012 Investigative Ophthalmology and Visual Science study by Vera et al. found that a single caffeinated coffee raised IOP by 3 to 4 mmHg in healthy subjects within 90 minutes. Removing caffeine removes this acute spike while preserving the chlorogenic acids that the Mendelian randomization data associates with long-term neuroprotective effects at the optic nerve. Decaf Cold Brew uses cold-water extraction, which produces lower concentrations of acidic compounds than hot-brewed coffee. For glaucoma patients who are minimizing all potential IOP inputs, cold brew decaf represents the lowest-stimulant coffee format available - removing both the caffeine-driven IOP mechanism and reducing the overall chemical complexity of the brew.Frequently Asked Questions
Does decaf coffee raise eye pressure?
Does decaf coffee raise eye pressure?
Based on the available evidence, no. A 2025 controlled study by Riaz et al. in the Journal of the Pakistan Medical Association tested 73 subjects and found that decaffeinated coffee produced no statistically significant change in intraocular pressure (p greater than 0.05), while caffeinated coffee caused a significant increase (p less than 0.001) in the same subjects. The authors concluded that caffeine is responsible for the acute IOP effect, and decaf does not produce it.
Can people with glaucoma drink decaf coffee?
Can people with glaucoma drink decaf coffee?
The current evidence suggests that decaf coffee does not acutely raise IOP, which is the primary concern for glaucoma patients. However, glaucoma management is individualized, and not all glaucoma is IOP-driven. Some patients have normal-tension glaucoma, where IOP is within the normal range but optic nerve damage still occurs. People with diagnosed glaucoma should discuss dietary choices including coffee consumption with their ophthalmologist, and should not make changes to their prescribed IOP-lowering regimen based on dietary changes alone.
Why does long-term caffeine appear protective against glaucoma if it raises IOP acutely?
Why does long-term caffeine appear protective against glaucoma if it raises IOP acutely?
This is a genuine paradox in the literature. A 2026 Mendelian randomization study by Dong et al. found that higher long-term plasma caffeine was associated with a 25% lower risk of primary open-angle glaucoma, with about 54% of that effect mediated through reduced IOP over the long term. The most plausible explanation is tolerance: people who consume caffeine habitually develop a tolerance to its acute IOP-elevating effect, while the long-term vascular and neuroprotective properties of caffeine may remain active.